The study of the antimicrobial activity of a soft dosage form with the antiviral effect
DOI:
https://doi.org/10.24959/cphj.19.1491Keywords:
antimicrobial activity, acyclovir, miramistin, soft dosage formAbstract
Nowadays there is a tendency towards the spread of viral diseases that cause significant complications to human health. Therefore, the question of creating new drugs that have a high antiviral effect is topical.
Aim. To study the antimicrobial activity of the pharmaceutical composition with acyclovir and miramistin in a soft dosage form with the antiviral effect.
Materials and methods. The objects of the study were model samples of the soft dosage form containing acyclovir and miramistin in the concentrations of 0.25 % (sample 1), 0.5 % (sample 2), 0.75 % (sample 3). Staphylococcus aureus АТСС 25293, Bacillus subtilis АТСС 6633, Escherichia coli АТСС 25922 and Candida albicans АТСС 885/653 were used as test cultures. The antimicrobial activity of the experimental samples was studied in vitro by the agar diffusion method.
Results and discussion. According to the results of the studies it has been found that all samples studied have a wide range of the antimicrobial action in relation to the test strains used (the diameter of the growth inhibition zones of test cultures is 13-26 mm). It has been proven that the culture of the test strain Staphylococcus aureus АТСС 25293 has a higher sensitivity to samples 2 and 3.
Conclusions. The studies of the antimicrobial activity of the soft dosage form with the antiviral effect in relation to different cultures of microorganisms have been conducted, and the optimal concentration of the active substance – miramistin, 0.5 %, has been experimentally substantiated.
References
Dmitriyevskiy, D. I., Bobritskaya, L. A. (2009). Zbirnik naukovih prats spivrobitnikiv NMAPO im. P. L. Shupika (Ukraine),18 (3), 335–340.
Rubleva, O. V. (2012). Rus. med. zhurn. 20, (11), 571–574.
Kazantseva, I. A., Kzantseva, N. N. (2016). Vestnik VolgGMU, 4 (60), 96–98.
Korovina, A. N., Kukhanova, M. K., Kochetkov, S. N. (2013). BIOTECHNOLOGIAACTA, 6(4), 78–85.
Celum, C, Wald, A, Lingappa, JR, Magaret, AS, Wang, RS. (2010). Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. The new England journal of medicine, 362 (4), 427 – 439. https://doi.org/10.1056/NEJMoa0904849
Dunayevskiy, A. M., Kirichenko, I. M. (2013). Poliklinika, 5, 6–12.
Kirichenko, I. M. (2013). Poliklinika, 6, 100–102.
Barinskiy, I. F., Alimbarova, L. M., Kirichenko, N. A., Svistov, V. V., Smirnov, I. V., Krivoshein, YU. S. (2012). Dermatovenerologiya i dermatokosmetologiya, 2, 28–31.
Volianskyi, Yu. L., Hhrytsenko, I. S., Shyrobokov, V. P. (2004). Vyvchennia spetsyfichoi aktyvnosti protymikrobnykh likarskykh zasobiv. Kyiv, 38.
10. Derzhavna Farmakopeia Ukrainy. 2-e vyd., 1. (2015). Kharkiv: Ukrainskyi naukovyi farmakopeinyi tsentr yakosti likarskykh zasobiv, 1128.
Downloads
Published
Issue
Section
License
Copyright (c) 2019 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
